MediPharm Labs Corp.

Our Promise: Purity Assured

Offering international quality standards to the Cannabis Industry with our purified cannabis concentrates.

Latest News

MediPharm Labs Corp. and Emerald Health Therapeutics, Inc. Sign Cannabis Concentrate Program Agreement

View Press Release All News

Spotlight

Oct 5, 2018

Extracting cannabis for beverage and edibles

View All

Careers

Sophisticated, Trusted, Innovative, Collaborative

Leaders in the Cannabis industry, our quality-focused team drives innovation through research, discipline, and collaboration. 

Learn More

Purity Assured

A leader in cannabis extraction and purification, MediPharm Labs has invested in an expert team, state-of-the-art technology, advanced methodologies and a purpose-built facility to deliver pure, safe and precisely-dosed cannabis concentrates and advanced derivative products.

A Focused Approach

MediPharm is a unique Licensed Producer with a singular focus on extraction and purification. This specialization drives leadership.

Learn More

Our Expert Team

Our research-driven team has deep bio-pharmaceutical experience, led by a renowned chromatography expert.

Learn More

International Quality Standards

Our cGMP and ISO standard of design and construction are currently the most innovative and technically advanced in the Canadian cannabis industry.

Learn More

Operational Excellence

Since June of 2018, MediPharm Labs has been producing purified cannabis concentrates with proven technology and proprietary methodologies.

Learn More

Forward Thinking

Cannabis 2.0 will be dominated by advanced derivative products. MediPharm is aligning with strategic partners and research institutions globally to meet consumer demand.

Learn More

Future Services

Canada

MediPharm Labs has a future as a connector in the cannabis industry, linking Licensed Producers with derivative product Manufacturers and Retailers through expert extraction, purification, product formulation, and processing. In March 2018, our company received our cannabis oil production license from Health Canada and have been extracting here in Ontario since June 2018. We anticipate receiving our Health Canada Cannabis Sales License during the fall of 2018.

Australia

MediPharm Labs has also launched in Australia, and pending Office of Drug Control Australia approval, will soon be producing cannabis oil. We are now taking enquiries for contract processing services and white label solutions. Be sure to check this page regularly as we add additional services in the exciting times ahead.

Contract Processing Services

View Service

White Label Production

View Service
Play

Latest News

MediPharm Labs Corp. and Emerald Health Therapeutics, Inc. Sign Cannabis Concentrate Program Agreement

MediPharm Labs Corp. (TSXV: LABS) (Formerly POCML 4 Inc.) Provides Corporate Update Upon Commencement of Trading on the TSXV

View All Press Releases

Leadership

  • Management Team

    MediPharm Labs is built on the foundation of a strong executive team, with professionals from complementary industries that include global pharmaceuticals, healthcare, energy, and biotechnology manufacturing.

  • Board of Directors

    The Board of Directors of MediPharm Labs Corp. is fully committed to our stakeholders and shareholders, providing oversight, governance and leadership to provide stability and growth over the long term.